DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Sotac Pharmaceuticals Limited (SOTAC) share price today?

Sotac Pharmaceuticals Limited (SOTAC) is trading at ₹90.05 on the NSE, up 0.00% on the day. Source: DocStoX.

What is the PE ratio of Sotac Pharmaceuticals Limited?

Sotac Pharmaceuticals Limited has a price-to-earnings (PE) ratio of 17.3 in the Healthcare sector.

What is the market capitalisation of Sotac Pharmaceuticals Limited?

Sotac Pharmaceuticals Limited has a market capitalisation of approximately ₹100 crore.

Is Sotac Pharmaceuticals Limited a profitable company?

Sotac Pharmaceuticals Limited generates a return on equity of 9.8% with a net profit margin of 5.7%. That is a modest return on shareholder capital.

What is the 52-week high and low of SOTAC?

Sotac Pharmaceuticals Limited (SOTAC) has traded between ₹86 and ₹139.65 over the past 52 weeks, against a current price of ₹90.05.

Does Sotac Pharmaceuticals Limited pay a dividend?

Yes. Sotac Pharmaceuticals Limited currently offers a dividend yield of 0.11%. Dividend payments depend on the board's declaration each year.

Sotac Pharmaceuticals Limited

₹90.05▲ +0.00 (+0.00%)

SOTAC·NSE·Healthcare

Market Cap

99.51 Cr

PE Ratio

17.25

Volume

1,200

Day High - Low

90.05 - 90.05

52W High-Low

139.65 - 86.00

₹90.05▲ +0.00 (+0.00%)

Market Cap99.51 Cr

PE Ratio17.25

Volume1,200

Day High - Low90.05 - 90.05

52W High-Low139.65 - 86.00

Sotac Pharmaceuticals Limited (SOTAC): company summary

The company's annual revenue rose 4.4% to ₹101 crore, but annual net profit fell 35.9% to ₹6 crore.

Sotac Pharmaceuticals Limited (SOTAC) is a micro-cap Healthcare company valued at ₹100 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move: Sotac Pharmaceuticals Limited last traded at ₹90.05, unchanged on the day.
Financial performance: The company's annual revenue rose 4.4% to ₹101 crore, but annual net profit fell 35.9% to ₹6 crore. The latest quarter saw revenue rise 27.7% to ₹60 crore, but net profit dropped 50.0% to ₹3 crore compared to the same quarter a year earlier. The net profit margin narrowed 3.6 percentage points to 5.7%.
Valuation multiples: The stock trades at 17.3 times earnings, a discount to the Healthcare median of 32.0, 1.69 times book value. It yields 0.1%.
Things to watch: The company's net profit fell 35.9% year-on-year, and the latest quarter's net profit dropped 50.0% compared to the same quarter a year earlier. The net profit margin narrowed 3.6 percentage points to 5.7%. The stock is 35.5% below its 52-week high.
Where it stands: The company's business shows mixed performance, with revenue growing but profit declining. The latest quarter's net profit fell 50.0% compared to the same quarter a year earlier. The stock is 35.5% below its 52-week high.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

This price may be out of date. Last traded ₹90.05 on 1 Oct 2026 (15 days ago). Not a live price.

DocStoX Score

5.0/10

Weak

Fair Value

ROE

9.79%

Average

P/E

17.25x

Fair

Debt / Equity

0.64

Moderate

Industry

Healthcare

Pharmaceuticals

Overall View

Mixed

Price performance

52W₹86.00

₹139.65

DocStoX take

Supported by growth (8.5) and risk (6.5), but held back by momentum (0.0). Growth looks strong at 8.5, but that is offset by momentum at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence

5.0

/10

Weak

Quality

Modest

ROE 9.8%

Valuation

Rich

P/E 17.3×

Growth

Strong

Revenue +15.6% 5Y CAGR

Risk

Moderate

D/E 0.64

Momentum

Weak

8% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹90

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹100 Cr

52W High / Low

₹140 / ₹86

Dividend Yield

0.11%

Promoter Holding

72.85%

EPS (TTM)

₹5.22

Book Value

₹53.28

Key highlights

Profit compounding 42% a year
Profitable in all of the last 5 years
Revenue compounding 16% a year
Momentum is weak (0.0/10)
Near the bottom of its 52-week range (8%)

3 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore Sotac Pharmaceuticals Limited’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Sotac Pharmaceuticals Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare Sotac Pharmaceuticals Limited with peers

Sotac Pharmaceuticals Limited vs Sun Pharmaceutical Industries Limited Sotac Pharmaceuticals Limited vs Divi's Laboratories Limited Sotac Pharmaceuticals Limited vs Torrent Pharmaceuticals Limited Sotac Pharmaceuticals Limited vs Apollo Hospitals Enterprise Limited Sotac Pharmaceuticals Limited vs Zydus Lifesciences Limited Sotac Pharmaceuticals Limited vs Laurus Labs Limited

Related tools & concepts

Value Sotac Pharmaceuticals Limited with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

SOTAC newsLatest coverage & filings Open screenerFilter the whole market